Related references
Note: Only part of the references are listed.Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Eugenio Barone et al.
MOLECULAR NEUROBIOLOGY (2019)
O-G1cNAcylation and neuronal energy status: Implications for Alzheimer's disease
Tiffany S. Pinho et al.
AGEING RESEARCH REVIEWS (2018)
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease
Antonella Tramutola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
O-GlcNAcylation: key regulator of glycolytic pathways
Zachary A. Bacigalupa et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2018)
Neuronal O-GlcNAc transferase regulates appetite, body weight, and peripheral insulin resistance
Chun-ling Dai et al.
NEUROBIOLOGY OF AGING (2018)
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
Nicholas B. Hastings et al.
MOLECULAR NEURODEGENERATION (2017)
Interplay between protein glycosylation pathways in Alzheimer's disease
Moran Frenkel-Pinter et al.
SCIENCE ADVANCES (2017)
O-GlcNAcylation: A regulator of tau pathology and neurodegeneration
Cheng-Xin Gong et al.
ALZHEIMERS & DEMENTIA (2016)
Effects of caloric restriction on O-GlcNAcylation, Ca2+ signaling, and learning impairment in the hippocampus of ob/ob mice
Byeong Tak Jeon et al.
NEUROBIOLOGY OF AGING (2016)
Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration
Andrew C. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Emerging Link between O-GlcNAc and Alzheimer Disease
Yanping Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
O-GIcNAc Modification of tau Directly Inhibits Its Aggregation without Perturbing the Conformational Properties of tau Monomers
Scott A. Yuzwa et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
Danielle L. Graham et al.
NEUROPHARMACOLOGY (2014)
Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice
Catherine E. Bennett et al.
LIFE SCIENCES (2013)
Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice
Peter Borghgraef et al.
PLOS ONE (2013)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yang Yu et al.
PLOS ONE (2012)
Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
Gerald W. Hart et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
O-GlcNAc modification, insulin signaling and diabetic complications
T. Issad et al.
DIABETES & METABOLISM (2010)
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Fei Liu et al.
BRAIN (2009)
Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease
Ying Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting
X Li et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)